Hamrick Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.46M Buy
9,826
+1,426
+17% +$508K 1.92% 15
2025
Q4
$2.75M Buy
+8,400
New +$2.66M 2.04% 14

Other funds holding AMGN

Hamrick Investment Counsel's AMGN Position: Q1 2026 in Review

Hamrick Investment Counsel increased its Amgen (AMGN) stake by 17% in Q1 2026, buying an estimated $508K and bringing the position to 9,826 shares worth $3.46M. The position accounts for 1.92% of the portfolio, ranked #15.

Hamrick Investment Counsel first reported a position in AMGN in Q4 2025 and has held it in 2 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Hamrick Investment Counsel held 9,826 shares of Amgen worth $3.46M as of Q1 2026.
  • Hamrick Investment Counsel bought 1,426 Amgen shares in Q1 2026, an estimated $508K.
  • Amgen made up 1.92% of Hamrick Investment Counsel's portfolio in Q1 2026, its #15 holding.
  • Hamrick Investment Counsel first reported a position in Amgen in Q4 2025 and has held it in 2 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Hamrick Investment Counsel's 13F filing for Q1 2026, filed 11 May 2026.